KIT D816V Mutation

2

Review clinical trials related to KIT D816V Mutation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.

Participants needed: 450
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Blueprint Medicines CorporationUpdated: Jun 25, 2026Locations: 19
Eligibility criteria

Documented anaphylaxis due to Hymenoptera venom with cardiovascular symptoms or [+7]

Monoclonal mast cell activation syndrome with a known KIT mutation [+4]

Status: Recruiting

Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis

This observational study aims to evaluate the diagnostic value and clinical utility of detecting the KIT-D816V mutation in the peripheral blood of adult patients with systemic mastocytosis (SM), using droplet digital PCR (ddPCR). Currently, the diagnosis of SM relies heavily on invasive bone marrow biopsies. This study will determine whether highly sensitive ddPCR testing of peripheral blood could provide a reliable, minimally invasive alternative for detecting the KIT-D816V mutation, which is a key driver of the disease and a major diagnostic criterion. The results could optimize the diagnostic process and continuous monitoring of adult SM patients.

Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: The First Affiliated Hospital of Soochow UniversityUpdated: May 1, 2026Locations: 1
Eligibility criteria

Age >= 18 years. [+3]

Patients from whom specimens cannot be obtained (e.g., due to comorbidities or c... [+4]